This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression

Siegfried Kasper, M.D.; Joseph R. Calabrese, M.D.; Gordon Johnson, M.B.B.S.; Osamu Tajima, Ph.D.; Eduard Vieta, M.D., Ph.D.; Adele C. Viguera, M.D.; Lakshmi N. Yatham, M.B.B.S., F.R.C.P.C.; and Allan H. Young, M.D., F.R.C.Psych

Published: October 31, 2008

Article Abstract

Click to enlarge page

In 2004, an International Consensus Group (ICG) developed and published recommendations for the treatment of bipolar I depression based on available clinical evidence. The ICG reconvened in October 2007 to reevaluate clinical trial data published in the intervening years on the treatment of bipolar I depression. In addition, the ICG extended the scope of its discussions to consider published evidence for the treatment of bipolar II depression and also special populations of patients with bipolar depression.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 69

Quick Links: